Press Releases

2017

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Moderna Publishes Preclinical Data in Cell Reports on mRNA Therapeutic to Treat Rare Liver Disease Methylmalonic Acidemia (MMA), A Disorder of Organic Acid Metabolism

Moderna 12.19.2017

Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors

Moderna 11.15.2017

Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure

Moderna 11.01.2017

Moderna Named One of Global Biopharmaceutical Industry’s Top Employers in Science Magazine’s Annual Survey

Moderna 10.19.2017

Stephen Berenson Joins Moderna’s Board of Directors

Moderna 10.10.2017

Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines

Moderna 09.26.2017

Moderna Announces Pipeline and Corporate Update

Moderna 09.14.2017

Industry Veteran Juan Andres Joins Moderna as Senior Vice President of Late Stage Technical Development and Manufacturing

Moderna 08.03.2017

Moncef M. Slaoui, Ph.D. Joins Moderna’s Board of Directors

Moderna 07.27.2017

Moderna Provides Update on mRNA Rare Disease R&D Strategy

Moderna 07.27.2017

Loading